Suppr超能文献

相似文献

2
Bivalent histone modifications in stem cells poise miRNA loci for CpG island hypermethylation in human cancer.
Epigenetics. 2011 Nov;6(11):1344-53. doi: 10.4161/epi.6.11.18021. Epub 2011 Nov 1.
3
A DNA hypermethylation module for the stem/progenitor cell signature of cancer.
Genome Res. 2012 May;22(5):837-49. doi: 10.1101/gr.131169.111. Epub 2012 Mar 5.
5
Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells.
Cancer Res. 2008 Jul 15;68(14):5753-9. doi: 10.1158/0008-5472.CAN-08-0700.
6
Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis.
Bioessays. 2007 Sep;29(9):842-5. doi: 10.1002/bies.20619.
9
Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation?
Cell Cycle. 2007 May 2;6(9):1040-3. doi: 10.4161/cc.6.9.4210. Epub 2007 May 28.

引用本文的文献

1
Epigenetic Modulation and Brain Function in Parkinson's Disease: The Role of Exercise Alone or Combined With Polyphenols.
Food Sci Nutr. 2025 Jul 28;13(8):e70696. doi: 10.1002/fsn3.70696. eCollection 2025 Aug.
2
BRAF maintains the CpG island methylator phenotype, and DNA methylation of PRC2 targets genes in colon cancer.
iScience. 2025 Jun 14;28(7):112905. doi: 10.1016/j.isci.2025.112905. eCollection 2025 Jul 18.
3
Direct genetic transformation bypasses tumor-associated DNA methylation alterations.
Genome Biol. 2025 Jul 17;26(1):212. doi: 10.1186/s13059-025-03650-2.
4
DNA methylation in melanoma immunotherapy: mechanisms and therapeutic opportunities.
Clin Epigenetics. 2025 Apr 30;17(1):71. doi: 10.1186/s13148-025-01865-5.
5
Gene expression profiling, prognosis, and immune microenvironment of KLF4 in malignancies.
PLoS One. 2025 Apr 29;20(4):e0322523. doi: 10.1371/journal.pone.0322523. eCollection 2025.
7
High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression.
Int J Mol Sci. 2025 Feb 27;26(5):2125. doi: 10.3390/ijms26052125.
8
Chromatin Remodulator CHD4: A Potential Target for Cancer Interception.
Genes (Basel). 2025 Feb 15;16(2):225. doi: 10.3390/genes16020225.
10
TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states.
Nat Cancer. 2025 Feb;6(2):385-403. doi: 10.1038/s43018-024-00900-3. Epub 2025 Jan 24.

本文引用的文献

1
Polycomb silencers control cell fate, development and cancer.
Nat Rev Cancer. 2006 Nov;6(11):846-56. doi: 10.1038/nrc1991.
2
A bivalent chromatin structure marks key developmental genes in embryonic stem cells.
Cell. 2006 Apr 21;125(2):315-26. doi: 10.1016/j.cell.2006.02.041.
3
Control of developmental regulators by Polycomb in human embryonic stem cells.
Cell. 2006 Apr 21;125(2):301-13. doi: 10.1016/j.cell.2006.02.043.
4
Polycomb complexes repress developmental regulators in murine embryonic stem cells.
Nature. 2006 May 18;441(7091):349-53. doi: 10.1038/nature04733. Epub 2006 Apr 19.
5
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.
Genes Dev. 2006 May 1;20(9):1123-36. doi: 10.1101/gad.381706. Epub 2006 Apr 17.
6
Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation.
PLoS Genet. 2006 Mar;2(3):e40. doi: 10.1371/journal.pgen.0020040. Epub 2006 Mar 31.
8
Chromatin signatures of pluripotent cell lines.
Nat Cell Biol. 2006 May;8(5):532-8. doi: 10.1038/ncb1403. Epub 2006 Mar 29.
9
Stem cells and cancer: two faces of eve.
Cell. 2006 Mar 24;124(6):1111-5. doi: 10.1016/j.cell.2006.03.011.
10
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
Nat Rev Cancer. 2006 Feb;6(2):107-16. doi: 10.1038/nrc1799.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验